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Abstract
Backround: We undertook a prospective study of all new central venous catheters inserted into
patients in the intensive care units, in order to identify the risk factors and to determine the effect
of glycopeptide antibiotics on catheter – related infections.
Methods: During the study period 300 patients with central venous catheters were prospectively
studied. The catheters used were nontunneled, noncuffed, triple lumen and made of polyurethane
material. Catheters were cultured by semiquantitative method and blood cultures done when
indicated. Data were obtained on patient age, gender, unit, primary diagnosis on admission,
catheter insertion site, duration of catheterization, whether it was the first or a subsequent
catheter and glycopeptide antibiotic usage.
Results: Ninety-one (30.3%) of the catheters were colonized and infection was found with 50
(16.7%) catheters. Infection was diagnosed with higher rate in catheters inserted via jugular vein in
comparison with subclavian vein (95% CI: 1.32–4.81, p = 0.005). The incidence of infection was
higher in catheters which were kept in place for more than seven days (95% CI 1.05–3.87, p = 0.03).
The incidence of infection was lower in patients who were using glycopeptide antibiotic during
catheterization (95% CI: 1.49–5.51, p = 0.005). The rate of infection with Gram positive cocci was
significantly lower in glycopeptide antibiotic using patients (p = 0.01). The most commonly isolated
organism was Staphylococcus aureus (n = 52, 37.1%).
Conclusion: Duration of catheterization and catheter insertion site were independent risk factors
for catheter related infection. Use of glycopeptide antibiotic during catheterization seems to have
protective effect against catheter related infection.
Background
Central venous catheters (CVCs) are widely used in criti-
cally ill patients throughout the developed world. They
permit hemodynamic monitoring and allow access for the
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administration of fluids, blood products, medications,
and total parenteral nutrition (TPN). Estimates of their
use in the United States alone suggest that over five mil-
lion CVCs are inserted annually [1,2]. Although CVCs
have significant benefits in many clinical situations, the
increase in their use over the last 20 years has been associ-
ated with at least a doubling of resultant nosocomial in-
fections [3,4]. A number of factors may contribute to the
risk of catheter related infections (CRI) [5–9]. Although a
common problem, the descriptive epidemiology, patho-
physiology, risk factors and best means of diagnosing CRI
have not yet been fully elucidated. We undertook a pro-
spective study of all new CVCs inserted into patients in the
intensive care units (ICU), in order to identify the risk fac-
tors and to determine the effect of glycopeptide antibiot-
ics on CRI.
Patients and Methods
Human research ethics committee approval was obtained
for the study. As there were no interventions, requirement
for written patient consent was waived. All patients admit-
ted to medical, neurosurgical and surgical ICUs of Istan-
bul Faculty of Medicine between January 2001 and
December 2001 who submitted to a CVC were included in
the study. The catheters used were nontunneled, non-
cuffed, triple lumen and made of polyurethane material
(Arrow, Erding, Germany). All catheters were inserted via
new percutaneous puncture in intensive care units by ex-
perienced anaesthetists under strict aseptic techniques. Af-
ter washing hands and forearms with antiseptic soap,
drying with a sterile towel, maximal sterile barrier precau-
tions (sterile gloves, longsleeved sterile gown, mask, cap,
and large sterile sheet drape) were observed prior to cath-
eter insertion. Povidone-iodine was used as antiseptic for
cleansing the CVC insertion site. After catheter insertion
the site was covered with sterile gauze. Every 48 hours the
dressing was removed, the site was inspected and cleansed
with povidone-iodine, and a new dressing was applied.
Catheters were followed for the duration of their insertion
and data were obtained daily on inflammation of the
catheter sites by a single observer. The catheters were re-
moved at the end of the day seven as scheduled replace-
ment is followed in the ICUs of our hospital. Catheters
were removed in less than seven days when the patient
had no more need for central line and suspected to have
CRI. There was provision for discretionary clinical judge-
ment to leave the catheter longer than seven days. Each
CVC was withdrawn aseptically using sterile forceps after
the area of insertion was washed with povidone – iodine
solution. The distal 5 cm of the catheter was cut off using
sterile scissor and sent aseptically to the clinical microbi-
ology laboratory where it was cultured by semiquantita-
tive method [10]. When blood cultures were indicated, 10
mL of venous blood was drawn from catheter and from
two peripheral veins following skin preparation with pov-
idone-iodine. Data were also obtained on patients age,
gender, unit, primary diagnosis on admission (catego-
rized as cardiorespiratory failure, trauma, postsurgical and
others), CVC insertion site, whether it was the first or a
subsequent catheter, duration of catheterization and glyc-
opeptide antibiotic usage.
Definition [1,3]
Colonized catheter: Growth of ≥ 15 colony forming units
(cfu) on semiquantitative culture from catheter tip in the
absence of accompanying clinical symptoms.
Exit site infection: Erythema, tenderness, induration, or
purulence within 2 cm of the skin at the exit site of the
catheter.
Definite catheter-related bacteremia (D-CRB): Isolation of
the same organism (i.e., identical species, antibiograms)
from semiquantative culture of the catheter and from the
blood (drawn from a peripheral veins) of a patient with
accompanying clinical symptoms of bloodstream infec-
tion and no other apparent source of infection.
Possible catheter-related bacteremia (P-CRB): Bacteremia
(isolation of the same organism with identical antibio-
grams from the blood drawn from peripheral veins and
CVC), clinical manifestations of sepsis, defervescence af-
ter removal of implicated catheter, but no laboratory con-
firmation of CVC colonization.
Statistical analysis
The chi-square or the Fisher's test was used to determine
the significant differences between categorical variables.
Mann-Whitney U test was used for the continuous varia-
bles. The variables that were found to be significant (p ≤
0.05) in the univariate analysis (catheter insertion site,
duration of catheterization and glycopeptide usage) were
taken into logistic regression. The software package used
for statistical analysis was SPSS for Windows Release 10.0
(SPSS Inc., Chicago, IL., U.S.A.).
Results
During the study period 300 patients with CVCs were as-
sessed. One hundred and seventy – six (58.6%) of the pa-
tients were from the general ICU, 92 (30.7%) were from
the surgical ICU and the other 32 (10.7%) were from the
neurosurgical ICU. The patients studied were 148
(49.3%) males and 152 (51.7%) females. The mean age
was 44 ± 21.1. The primary diagnosis of the patients were
as follows; 81 (27%) cardiorespiratory failure, 72 (%24)
trauma, 72 (24%) postsurgical and 75 (25%) others.
CVCs were inserted either into jugular vein (n = 132,
44%) or into the subclavian vein (n = 168, 56%). Twenty
– eight (9.3%) patients were receiving TPN. The mean
length of time the catheter was kept in place was 7 ± 2.8Annals of Clinical Microbiology and Antimicrobials 2003, 2 http://www.ann-clinmicrob.com/content/2/1/3
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days. Two hundred and one (67%) CVCs were kept in
place for seven days or less and the other 99 (33%) CVCs
were kept in place for more than seven days. Eighty four
(28%) of them at the time of catheter insertion, a total of
113 (37.6%) patients were using glycopeptide antibiotic
during catheterization. The other 187 (62.4%) patients
were not using glycopeptide antibiotic at the time of cath-
eter insertion and for the duration of insertion (Table 1).
Ninety-one (30.3%) of the CVCs were colonized and the
CRI was found with 50 (16.7%) catheters. Of the CRIs; 28
(%9.3) D-CRB, 8 (2.7%) P-CRB and 17 (5.6%) exit site in-
fection was diagnosed. Three (1%) patients had both D-
CRB and exit site infection. The unadjusted risk ratios of
risk factors are given in Table 1. No significant difference
were found for age, gender, unit, primary diagnosis, re-
peated catheterization and TPN use. CRI was diagnosed
with higher rate (n = 30, 22.7%) in CVCs inserted via jug-
ular vein in comparison with subclavian vein (n = 20,
11.9%) (p = 0.01). The incidence of CRI (n = 24, 24.2%)
was higher in catheters which were kept in place for more
than seven days (p = 0.01). The incidence of CRI was also
higher in patients who were not using glycopeptide anti-
biotic (n = 45, 24.0%) than patients who were using
glycopeptide antibiotic during catheterization (n = 5,
4.4%) (p = 0.001). The results of the multivariate analysis
are broadly in agreement with the univariate analysis (Ta-
ble 2). Use of a jugular insertion site has an odds ratio of
2.52 (95% CI: 1.32–4.81, p = 0.005) compared with pa-
tients with a CVC inserted into the subclavian vein. Cath-
eters kept in place for more than seven days has an odds
ratio of 2.02 (95% CI 1.05–3.87, p = 0.03) compared with
catheters kept in place for seven days or less. When the pa-
tients using glycopeptide antibiotic were taken as the ref-
erence category, the patients who were not using these
antibiotic during catheterization had an increased risk
with an odds ratio of 3.01 (95% CI: 1.49–5.51, p= 0.005).
One hundred and fourty-eight organisms were isolated as
the cause of catheter colonization or CRI. Seventy – nine
(53.4%) Gram-positive cocci, 66 (44.5%) Gram-negative
bacilli and three (2.1%) yeasts were isolated. The most
commonly isolated organism was Staphylococcus aureus (n
= 52, 37.1%) followed by Pseudomonas aeruginosa (n = 27,
19.3%), Staphylococcus epidermidis (n = 26, %18.6) and
Acinetobacter spp (n = 21, %15) (Table 3). Of the 50 cases
Table 1: The association between CRI and the risk factors (univariate analysis)
Risk groups Total CRI RR* (%95 CI**) p value
n( % )n( % )
Unit
Surgical ICU 92 (30.7) 20 (21.7) 1.53 (0.90–2.60) 0.12
Neurosurgical ICU 32 (10.7) 5 (15.6) 1.10 (0.46–2.66) 0.79
Medical ICU 176 (58.6) 25 (14.2) 1.00
Gender
Male 148 (49.3) 25 (16.9) 1.03 (0.62–1.70) 0.92
Female 152 (50.7) 25 (16.4) 1.00
CVC insertion site
Jugular vein 132 (44) 30 (22.7) 1.91 (1.14–3.20) 0.01
Subclavian vein 168 (56) 20 (11.9) 1.00
Repeated catheterization
Subsequent catheters 197 (65.7) 34 (17.2) 1.13 (0.54–2.72) 0.87
First catheter inserted 103 (34.3) 16 (15.5) 1.00
Total parenteral nutrition
No 272 (90.7) 46 (16.9) 1.18 (0.46–3.05) 0.99
Yes 28 (9.3) 4 (14.3) 1.00
Primary diagnosis
Cardiorespiratory failure 81 (27) 14 (19.4) 0.97 (0.51–1.87) 0.93
Trauma 72 (24) 9 (12.5) 0.63 (0.29–1.34) 0.22
Postsurgical 72 (24) 12 (14.8) 0.74 (0.37–1.48) 0.39
Others 75 (25) 15 (20.0) 1.00
Duration of catheterization
≥ 8 day 99 (33) 24 (24.2) 1.87 (1.14–3.09) 0.01
≤ 7 day 201 (67) 26 (12.9) 1.00
Glycopeptide usage
No 187 (62.4) 45 (24.0) 4.45 (1.46–3.14) 0.001
Yes 113 (37.6) 5 (4.4) 1.00
RR*: Risk ratio 95%CI**: 95% confidence intervalAnnals of Clinical Microbiology and Antimicrobials 2003, 2 http://www.ann-clinmicrob.com/content/2/1/3
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of CRI, most of the organisms causing infection were
Gram-positive cocci (n = 38, 76%), with the most com-
monly isolated organism being S. aureus (n = 32, 64%)
(Table 3). All of the Staphylococcus spp. were resistant to
methicilline.
The etiology of CRI was predominantly Gram-positive
cocci (n = 32, 71.1%) in patients who were not using glyc-
opeptide antibiotic during catheterization. In contrast, in
patients who were using glycopeptide antibiotic during
catheterization Gram-positive cocci was only responsible
from one (%20) CRI. This difference was significant (p =
0.01).
Discussion
Many different risk factors for CRI in intensive care pa-
tients have been reported in the literature [3,4,8,9,11–13].
These include insertion site, duration of catheterization,
type of dressing, type of catheter, frequent manipulations,
improper aseptic techniques, number of catheter lumens,
type of topical antiseptic solution used and use of the
catheter for TPN. The relative importance of one risk fac-
tor over another is diffucult to assess given that in most
studies only univariate analysis has been performed and
estimates of the risk of each factor has not been attempt-
ed. We performed a logistic regression to assess the major
determinants of CRI and found that the independent pre-
dictors of CRI were catheter insertion site, duration of
catheterization and antibiotic (glycopeptide) usage.
In our study infection rates of catheters inserted into jug-
ular vein and subclavian vein were 22.7%, 11.9% respec-
tively (p = 0.005). The CVCs inserted to the jugular vein
were associated with approximately two and a half times
the risk of infection compared with CVC inserted to sub-
clavian vein in the multivariate analysis. It is also reported
in other studies that colonization and infection is more
likely in catheters inserted to jugular vein than in catheters
inserted to subclavian vein [1,3,14]. Reasons for the high-
er infection rate in the jugular vein site is thought to be re-
lated to difficulty keeping the dressing in place and
contamination with oropharyngeal secretions. Therefore,
for catheters inserted to jugular vein, the manipulations
should be done with more caution and the oropharyngeal
secretions should be prevented to contaminate the cathe-
ter. Most of the phycians select the jugular vein for cathe-
ter insertion because it is easier to insert the catheter and
due to low mechanical complication rate. According to
our study and other reports, subclavian vein approach has
a significant advantage with respect to insertion site colo-
nization and infection [6,15,16]. Therefore, we suggest
that the subclavian approach be utilized preferentially for
catheterization, provided a serious bleeding diathesis is
not present and risk of pneumothorax is not excessive.
Table 2: The association between CRI and the risk factors (multivariate analysis)
Risk factors β coefficient Standard deviation OR* 95% CI P value
CVC insertion site
Jugular vein 0.92 0.33 2.52 (1.32–4.81) 0.005
Subclavian vein 1.00
Duration of 
catheterization
≥ 8 day 0.70 0.33 2.02 (1.05–3.87) 0.03
≤ 7 day 1.00
Glycopeptide usage
No 1.10 0.39 3.01 (1.49–5.51) 0.005
Yes 1.00
OR*: Odds ratio 95%CI**: 95% confidence interval
Table 3: Microorganisms isolated from catheter tip and CRI
Organisms Frequency of 
microorganism 
isolated from 
catheter tip
Frequency of 
microorganism 
isolated from CRI
n (%) n (%)
Gram-positive cocci 71 (50.7) 38 (76)
S. aureus 47 (33.5) 32 (64)
S. epidermidis 23 (16.4) 6 (12)
Enterococcus sp. 1 (0.7) - (-)
Gram-negative bacilli 66 (47.1) 12 (24)
P. aeruginosa 27 (19.2) 3 (6)
Acinetobacter spp. 21 (15) 2 (4)
Enterobacter spp. 5 (3.6) - (-)
K. oxytoca 5 (3.6) 5 (10)
E. coli 3 (2.2) 1 (2)
K. pneumoniae 3 (2.2) 1 (2)
Serratia marcescens 2 (1.4) - (-)
Candida spp 3 (2.2) - (-)Annals of Clinical Microbiology and Antimicrobials 2003, 2 http://www.ann-clinmicrob.com/content/2/1/3
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In our study the CRI rate was higher for CVCs kept in place
for ≥ 8 days (24.2%) in comparison to catheters kept in
place for ≤ 7 days (12.9%) (p = 0.03). The CVCs kept in
place for ≥ 8 days were associated with approximately two
times the risk of infection compared with catheters kept in
place for ≤ 7 days. The practise of routinely changing cath-
eters according to some defined time period to reduce the
risk of CRI is commonly referred to as "scheduled" re-
placement [3,7]. There is little or no support from the lit-
erature for scheduled replacement, even though it
continues to be a common clinical practice. Cook et al
looked at the evidence for scheduled replacement using
guide-wire exchanges and/or new site replacements[17].
They found no evidence that scheduled replacement, us-
ing either of the replacement techniques, at three days or
seven days had any advantage over a replacement based
on clinical indication. The other studies also failed to
prove any reduction of CRI rates by scheduled replace-
ment[18,19]. While catheter tip colonization and CRI
may increase with CVC duration controversy still exists re-
garding scheduled changes.
We found that the incidence and risk of CRI was lower in
patients using glycopeptide antibiotic during catheteriza-
tion in comparison to patients who were not using these
antibiotics (p = 0.005). Gram-positive cocci, particularly
coagulase-negative Staphylococci (CNS) and S. aureus, are
responsible for at least two-thirds of the CRI [12,20].
Glycopeptide antibiotics are active against Staphylococci,
including methicillin resistant isolates, which was also the
most frequently isolated organism in our study. Therefore
we searched the effect of these antibiotics against CRI.
There is a lack of clarity in the literature about the defini-
tion and influence of antimicrobial use. There are only a
few reports that, antimicrobials administered at the time
of or immediately after insertion of a CVC may reduce the
incidence of CRI [21–23]. Other trials demonstrated no
benefit of such prophylaxis. [24–26]. According to our re-
sults, it seems that their use may prevent catheters from in-
fection especially with Gram – positive cocci. The
glycopeptide antibiotics the patients were using during
the catheterization seems to have prophylactic effect. This
study also concludes that patients using antibiotics effec-
tive against Gram – positive cocci during catheterization,
Gram – negative organisms should also be suspected as
the cause of CRI and antibiotics which are also effective
against these pathogens should be started empirically.
Further studies are needed to assess the additional benefit
afforded by antimicrobials in reducing CRI.
In this prospective study, the rate of CRI was found to be
16.7%. The rate of catheter-related bloodstream infections
(CRBIs) and exit site infection was 12% and 5.6% respec-
tively. Of the CRBIs, 28 (77.8%) were diagnosed as D-CRB
and the other 8 (22.2%) were diagnosed as P-CRB. P-CRB
was diagnosed when bacteremia and clinical manifesta-
tions of sepsis resolved after removal of implicated cathe-
ter in case of the organism causing bacteremia not
identified at any other site that is possible source. As stat-
ed in the definition of P-CRB we could not isolate the re-
sponsible organisms causing bloodstream infection from
the catheter tip in approximately 22% of the CRBI. It is
possible for organisms to originate from the internal sur-
face or the hub of the catheters. The method which we
used to culture the catheter tip (semiquantative method)
has a limitation in that it can take samples only from the
external surfaces of catheters and may not retrieve organ-
isms from the internal surfaces of the catheters [10].
Quantitative culture techniques, including the sonication
and vortexing methods [27–29], have the advantage of
isolating organisms from the external and internal surfac-
es of the catheters and possibly releasing organisms em-
bedded within the biofilm layer. Other reports comparing
semiquantitative catheter segment culture with quantita-
tive culture methods supports the superiority of quantita-
tive culture methods [30]. Thus, although the
semiquantitative catheter segment culture is one of the
least expensive tests for a clinical microbiology laboratory
to perform and the most frequently used method in hos-
pital laboratories, quantitative culture methods should be
preferred for catheter tip culture.
A number of investigators have examined the microbiol-
ogy of CRIs. S. epidermidis were the most common organ-
ism growing followed by P. aeruginosa, yeasts, enterococci,
S. aureus and Enterobacter spp. [29]. In our study the lead-
ing organism causing CVC colonization and CRI was S.
aureus followed by P. aeruginosa, K. oxytoca, S. epidermidis
and Acinetobacter spp. Although the ratio of Gram-positive
cocci to Gram-negative rods isolated from all catheters
was approximately 1, the ratio increased approximately
three fold in CRI. The finding that Staphylococcus spp. was
the most common positive catheter tip isolate seems to
support the current view that infection originates either
from the patients own skin flora or that of medical per-
sonnel or from hub colonization.
Conclusion
Duration of catheterization and catheter insertion site
were independent risk factors for catheter related infec-
tion. We found that the incidence and risk of CRI was low-
er in patients who were using glycopeptide antibiotics
during catheterization in comparison to patients who
were not using these antibiotics. It seems that use of glyc-
opeptide antibiotics during catheterization has a protec-
tive effect against catheter ralated infection but further
studies are needed to assess the benefit. Although the sem-
iquantitative catheter segment culture is one of the least
expensive tests for a clinical microbiology laboratory to
perform and the most frequently used method in hospitalAnnals of Clinical Microbiology and Antimicrobials 2003, 2 http://www.ann-clinmicrob.com/content/2/1/3
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laboratories, quantitative culture methods should be pre-
ferred for catheter tip culture.
List of abbreviations used
CVC Central venous catheter
CRI Catheter related infection
CFU Colony forming unit
CNS Coagulase negative Staphylococci
TPN Total parenteral nutrition
ICU Intensive care unit
D-CRB Definite catheter related bacteremia
P-CRB Possible catheter related bacteremia
Authors' contributions
SÖ carried out the study, designed the study, written the
manuscript. HO designed the study, supervised its coordi-
nation. AY participated in carrying the study. PA per-
formed the statistical analysis. NC participated in design
and coordination. HE participated in design and coordi-
nation. SC participated in design and coordination.
References
1. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO,
Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad I,
Randolph A and Weinstein RA Guidelines for the prevention of
intravascular catheter-related infections. Centers for Dis-
ease Control and Prevention MMWR Recomm Rep 2002, 51:1-29
2. Raad I and Bodey GP Infectious complications of indwelling vas-
cular catheters Clin Infect Dis 1992, 15:197-208
3. Fraenkel DJ, Rickard C and Lipman J Can we achieve consensus
on central venous catheter-related infections? Anaesth Intensive
Care 2000, 28:475-490
4. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW and
Lipsett PA Increased resource use associated with catheter-
related bloodstream infection in the surgical intensive care
unit Arch Surg 2001, 136:229-234
5. Maki DG and Ringer M Risk factors for infusion-related phlebitis
with small peripheral venous catheters. A randomized con-
trolled trial Ann Intern Med 1991, 114:845-854
6. Sitges-Serra A, Pi-Suner T, Garces JM and Segura M Pathogenesis
and prevention of catheter-related septicemia  Am J Infect
Control 1995, 23:310-316
7. Reed CR, Sessler CN, Glauser FL and Phelan BA Central venous
catheter infections: concepts and controversies Intensive Care
Med 1995, 21:177-183
8. Raad I Intravascular-catheter-related infections  Lancet 1998,
351:893-898
9. Crump JA and Collignon PJ Intravascular catheter-associated
infections Eur J Clin Microbiol Infect Dis 2000, 19:1-8
10. Maki DG, Weise CE and Sarafin HW A semiquantitative culture
method for identifying intravenous-catheter-related
infection N Engl J Med 1977, 296:1305-1309
11. Afif C and Raad I Intravascular catheter-related infections Cur-
rent Therapy of Infectious Diseases (Edited by: Schlossberg D) St.Louis,
Mosby 2001, 416-418
12. Bouza E, Burillo A and Munoz P Catheter-related infections: di-
agnosis and intravascular treatment Clin Microbiol Infect 2002,
8:265-274
13. Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B,
Flynn L, Hayes S, Strong S, Cruz J, Bowton DL, Hulgan T and Haponik
EF Education of physicians-in-training can decrease the risk
for vascular catheter infection Ann Intern Med 2000, 132:641-648
14. Eggimann P and Pittet D Overview of catheter-related infections
with special emphasis on prevention based on educational
programs Clin Microbiol Infect 2002, 8:295-309
15. Mermel LA, McCormick RD, Springman SR and Maki DG The
pathogenesis and epidemiology of catheter-related infection
with pulmonary artery Swan-Ganz catheters: a prospective
study utilizing molecular subtyping Am J Med 1991, 91:197S-
205S
16. Mermel LA Prevention of intravascular catheter-related
infections Ann Intern Med 2000, 132:391-402
17. Cook D, Randolph A, Kernerman P, Cupido C, King D, Soukup C and
Brun-Buisson C Central venous catheter replacement strate-
gies: a systematic review of the literature Crit Care Med 1997,
25:1417-1424
18. Cobb DK, High KP, Sawyer RG, Sable CA, Adams RB, Lindley DA,
Pruett TL, Schwenzer KJ and Farr BM A controlled trial of
scheduled replacement of central venous and pulmonary-ar-
tery catheters N Engl J Med 1992, 327:1062-1068
19. Uldall PR, Merchant N, Woods F, Yarworski U and Vas S Changing
subclavian haemodialysis cannulas to reduce infection Lancet
1981, 1:1373
20. Fatkenheuer G, Cornely O and Seifert H Clinical management of
catheter-related infections Clin Microbiol Infect 2002, 8:545-550
21. Lim SH, Smith MP, Machin SJ and Goldstone AH A prospective ran-
domized study of prophylactic teicoplanin to prevent early
Hickman catheter-related sepsis in patients receiving inten-
sive chemotherapy for haematological malignancies  Eur J
Haematol Suppl 1993, 54:10-13
22. Bock SN, Lee RE, Fisher B, Rubin JT, Schwartzentruber DJ, Wei JP,
Callender DP, Yang JC, Lotze MT, Pizzo PA and et al. A prospective
randomized trial evaluating prophylactic antibiotics to pre-
vent triple-lumen catheter-related sepsis in patients treated
with immunotherapy J Clin Oncol 1990, 8:161-169
23. Al-Sibai MB, Harder EJ, Faskin RW, Johnson GW and Padmos MA
The value of prophylactic antibiotics during the insertion of
long-term indwelling silastic right atrial catheters in cancer
patients Cancer 1987, 60:1891-1895
24. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG and Scarffe JH
Double-blind placebo controlled study of vancomycin proph-
ylaxis for central venous catheter insertion in cancer
patients J Hosp Infect 1990, 15:95-102
25. McKee R, Dunsmuir R, Whitby M and Garden OJ Does antibiotic
prophylaxis at the time of catheter insertion reduce the inci-
dence of catheter-related sepsis in intravenous nutrition? J
Hosp Infect 1985, 6:419-425
26. Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B and Ringden O
Peroperative teicoplanin for prevention of gram-positive in-
fections in neutropenic patients with indwelling central ve-
nous catheters: a randomized, controlled study Support Care
Cancer 1997, 5:485-488
27. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S and Rapin M
Diagnosis of central venous catheter-related sepsis. Critical
level of quantitative tip cultures Arch Intern Med 1987, 147:873-
877
28. Cleri DJ, Corrado ML and Seligman SJ Quantitative culture of in-
travenous catheters and other intravascular inserts J Infect Dis
1980, 141:781-786
29. Sherertz RJ, Raad ,II, Belani A, Koo LC, Rand KH, Pickett DL, Straub
SA and Fauerbach LL Three-year experience with sonicated
vascular catheter cultures in a clinical microbiology
laboratory J Clin Microbiol 1990, 28:76-82
30. Siegman-Igra Y, Anglim AM, Shapiro DE, Adal KA, Strain BA and Farr
BM Diagnosis of vascular catheter-related bloodstream infec-
tion: a meta-analysis J Clin Microbiol 1997, 35:928-936